Xuebin Qu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Xuebin Qu has a total of 58 co-authors. Here are the top co-authors by number of shared publications:
Jingjing Han
Department of Basic Medical Science, Jiangsu Medical College, Yancheng
7 shared publicationsCong Cao
The Fourth People’s Hospital of Yancheng, Yancheng
5 shared publicationsRui Hong
Department of Basic Medical Science, Jiangsu Medical College, Yancheng
4 shared publicationsYa Yang
Group Health Section The Affiliated Yancheng Maternity & Child Health Hospital of Yangzhou University Yancheng Jiangsu 224000 China
3 shared publicationsAihua Zhou
The Fourth People’s Hospital of Yancheng, Yancheng
2 shared publications- Aihua Zhou
Department of Psychiatry, The Fourth People's Hospital of Yancheng, Yancheng, 224003, China.
2 shared publications
Latest Publications
- Open Access
- 10 April 2026
- Published by Frontiers Media SA in Frontiers in Cellular Neuroscience
- Vol. 20, 1798965
Cynanchum bungei Decne-derived extracellular vesicles alleviate cognitive impairment and pathological damage in Alzheimer’s disease
Introduction: Cynanchum bungei Decne (CB) is known for its therapeutic benefits for neurodegenerative conditions as anti-inflammatory, antioxidant, and barrier significantly limits their potential advantages. Given the ability of crossing the barrier with minimal toxicity, extracellular vesicles derived from CB (CB-EVs) were utilized as an innovative approach to mitigate Alzheimer’s disease (AD). Methods: CB-EVs were isolated using gradient ultracentrifugation and identified via TEM imaging, nanoparticle tracking analysis, marker identification, and in vivo imaging system. Ten-month-old triple transgenic AD (3xTg-AD) mice received intravenous administration of CB-EVs at doses of 10 or 20 mg/kg every 3 days for the cognitive and pathological assessments. The human APP Swedish mutation transgenic SH-SY5Y cells were constructed as Aβ-induced neural damage model, and different concentrations of CB-EVs were added into medium to analyze its roles on cell viability, transcriptome changes, oxidative stress, and mitochondrial damage. Results: CB-EVs exhibited standard morphological and molecular traits, accumulating in the cerebral cortex and hippocampus. Two months of CB-EVs treatment alleviated cognitive impairments, diminished Aβ plaque, reduced Tau protein hyperphosphorylation, and lessened neuronal loss in 3xTg-AD mice. In transgenic SH-SY5Y cells, CB-EVs improved cell viability, enhanced superoxide dismutase activity, downregulated oxidative stress related NUPR1 and CHOP expression, decreased reactive oxygen species, lipid peroxidation, and malondialdehyde levels, reduced mitochondrial damage. Conclusion: These results demonstrated that CB-EVs could protect neurons from oxidative stress, attenuate cognitive impairment and pathological damage in AD.
- 10 April 2026
- Published by Frontiers Media SA in Frontiers in Cellular Neuroscience
- Vol. 20, 1798965
Open AccessCynanchum bungei Decne-derived extracellular vesicles alleviate cognitive impairment and pathological damage in Alzheimer’s disease
Introduction: Cynanchum bungei Decne (CB) is known for its therapeutic benefits for neurodegenerative conditions as anti-inflammatory, antioxidant, and barrier significantly limits their potential advantages. Given the ability of crossing the barrier with minimal toxicity, extracellular vesicles derived from CB (CB-EVs) were utilized as an innovative approach to mitigate Alzheimer’s disease (AD). Methods: CB-EVs were isolated using gradient ultracentrifugation and identified via TEM imaging, nanoparticle tracking analysis, marker identification, and in vivo imaging system. Ten-month-old triple transgenic AD (3xTg-AD) mice received intravenous administration of CB-EVs at doses of 10 or 20 mg/kg every 3 days for the cognitive and pathological assessments. The human APP Swedish mutation transgenic SH-SY5Y cells were constructed as Aβ-induced neural damage model, and different concentrations of CB-EVs were added into medium to analyze its roles on cell viability, transcriptome changes, oxidative stress, and mitochondrial damage. Results: CB-EVs exhibited standard morphological and molecular traits, accumulating in the cerebral cortex and hippocampus. Two months of CB-EVs treatment alleviated cognitive impairments, diminished Aβ plaque, reduced Tau protein hyperphosphorylation, and lessened neuronal loss in 3xTg-AD mice. In transgenic SH-SY5Y cells, CB-EVs improved cell viability, enhanced superoxide dismutase activity, downregulated oxidative stress related NUPR1 and CHOP expression, decreased reactive oxygen species, lipid peroxidation, and malondialdehyde levels, reduced mitochondrial damage. Conclusion: These results demonstrated that CB-EVs could protect neurons from oxidative stress, attenuate cognitive impairment and pathological damage in AD.
- Open Access
- 8 December 2025
- Published by Springer Nature in npj Parkinson's Disease
- Vol. 12 (1)
Classifying the risk of cognitive impairment in Parkinson’s disease using serum bile acid profiles and machine learning
Cognitive impairment (CI) is a common and early non-motor manifestation of Parkinson’s disease (PD), yet its biochemical basis remains poorly understood. Given the emerging link between bile acids (BAs) and neurodegeneration, we investigated whether serum BA profiles differ by cognitive status in PD and whether they can classify CI. A total of 363 participants were enrolled, including 63 healthy controls, 154 PD patients with normal cognition, and 146 with CI. Serum BA concentrations were quantified by ultra-performance liquid chromatography–tandem mass spectrometry, and multivariate as well as machine learning analyses were applied. Compared with cognitively normal PD patients, those with CI exhibited distinct BA alterations, characterized by elevated deoxycholic and cholic acids and reduced glyco- and tauro-conjugated species. Deoxycholic acid showed the strongest negative correlations with cognitive scores. Machine learning models based on combined BA profiles, particularly the random forest classifier, achieved robust discrimination between PD-CI and PD-NC groups (AUC up to 0.90). These findings indicate that BA dysregulation is closely linked to cognitive impairment in PD and may serve as a promising metabolic biomarker for early detection. Clinical trial number. Not applicable.
- 8 December 2025
- Published by Springer Nature in npj Parkinson's Disease
- Vol. 12 (1)
Open AccessClassifying the risk of cognitive impairment in Parkinson’s disease using serum bile acid profiles and machine learning
Cognitive impairment (CI) is a common and early non-motor manifestation of Parkinson’s disease (PD), yet its biochemical basis remains poorly understood. Given the emerging link between bile acids (BAs) and neurodegeneration, we investigated whether serum BA profiles differ by cognitive status in PD and whether they can classify CI. A total of 363 participants were enrolled, including 63 healthy controls, 154 PD patients with normal cognition, and 146 with CI. Serum BA concentrations were quantified by ultra-performance liquid chromatography–tandem mass spectrometry, and multivariate as well as machine learning analyses were applied. Compared with cognitively normal PD patients, those with CI exhibited distinct BA alterations, characterized by elevated deoxycholic and cholic acids and reduced glyco- and tauro-conjugated species. Deoxycholic acid showed the strongest negative correlations with cognitive scores. Machine learning models based on combined BA profiles, particularly the random forest classifier, achieved robust discrimination between PD-CI and PD-NC groups (AUC up to 0.90). These findings indicate that BA dysregulation is closely linked to cognitive impairment in PD and may serve as a promising metabolic biomarker for early detection. Clinical trial number. Not applicable.
- Open Access
- 4 November 2025
- Published by Wiley in CNS Neuroscience & Therapeutics
- Vol. 31 (11) , e70644
Myricetin Suppresses Inflammatory Th17 Polarization to Mitigate Alzheimer's Disease Pathogenesis
Aims: This study aimed to investigate the therapeutic potential of myricetin, a natural flavonoid, in Alzheimer's disease (AD) by targeting Th17 cell‐mediated neuroinflammation through inhibition of the transcription factor RORγt. Methods: Virtual screening of 47,963 compounds identified myricetin as a potential RORγt inhibitor, validated by molecular docking and dynamics simulations. In vivo, 3xTg‐AD mice were treated with myricetin (50 mg/kg/day) for 8.5 weeks, followed by behavioral tests (novel object recognition, Morris water maze) and pathological analyses (HE/Nissl staining, immunohistochemistry, Western blot). In vitro, Th17 polarization assays and mechanistic studies (ChIP, EMSA, MST) were performed to elucidate myricetin's action on RORγt‐IL‐17 signaling. Results: Myricetin exhibited stable binding to RORγt (Kd = 6.40 μM), suppressing Th17 polarization and IL‐17 production. In AD mice, myricetin improved cognitive function, reduced neuronal damage, decreased Aβ plaques and phosphorylated tau levels, and attenuated microglial activation. Mechanistically, myricetin blocked RORγt recruitment to the IL17 promoter, downregulating IL‐17 transcription. Conclusion: Myricetin ameliorates AD pathology by inhibiting RORγt‐driven Th17 polarization, highlighting its potential as a therapeutic agent for AD.
- 4 November 2025
- Published by Wiley in CNS Neuroscience & Therapeutics
- Vol. 31 (11) , e70644
Open AccessMyricetin Suppresses Inflammatory Th17 Polarization to Mitigate Alzheimer's Disease Pathogenesis
Aims: This study aimed to investigate the therapeutic potential of myricetin, a natural flavonoid, in Alzheimer's disease (AD) by targeting Th17 cell‐mediated neuroinflammation through inhibition of the transcription factor RORγt. Methods: Virtual screening of 47,963 compounds identified myricetin as a potential RORγt inhibitor, validated by molecular docking and dynamics simulations. In vivo, 3xTg‐AD mice were treated with myricetin (50 mg/kg/day) for 8.5 weeks, followed by behavioral tests (novel object recognition, Morris water maze) and pathological analyses (HE/Nissl staining, immunohistochemistry, Western blot). In vitro, Th17 polarization assays and mechanistic studies (ChIP, EMSA, MST) were performed to elucidate myricetin's action on RORγt‐IL‐17 signaling. Results: Myricetin exhibited stable binding to RORγt (Kd = 6.40 μM), suppressing Th17 polarization and IL‐17 production. In AD mice, myricetin improved cognitive function, reduced neuronal damage, decreased Aβ plaques and phosphorylated tau levels, and attenuated microglial activation. Mechanistically, myricetin blocked RORγt recruitment to the IL17 promoter, downregulating IL‐17 transcription. Conclusion: Myricetin ameliorates AD pathology by inhibiting RORγt‐driven Th17 polarization, highlighting its potential as a therapeutic agent for AD.
- Open Access
- 15 May 2025
- Published by Springer Nature in BMC Psychiatry
- Vol. 25 (1) , 494
Relationship between renal function and cognitive impairment in patients with stable schizophrenia: a multicenter cross-sectional study
Clinically stable inpatients with schizophrenia have generalized impairment of cognitive function along with abnormalities in renal function, but the link between cognitive function and renal function has been underexplored. This study enrolled 216 hospitalized patients with clinically stable schizophrenia. Demographic and renal function parameters were collected from electronic medical records. Cognitive function was assessed using the Chinese Brief Cognitive Test (C-BCT). To analyze the correlations between renal function and processing speed, attention, working memory, and executive function in patients hospitalized with clinically stable schizophrenia. Covariate-adjusted linear and multivariate logistic regression models were constructed to determine the relationship between renal function and cognitive function. ROC analysis was used to further investigate the prediction of renal function indices in assessing stable schizophrenia inpatients. Significant variations in serum Cystatin C (CysC), β2-microglobulin (β2-MG), and uric acid (UA) levels were observed among hospitalized patients with clinically stable schizophrenia across different cognitive impairment severities. Correlation analysis revealed a significant association between serum CysC levels and C-BCT scores in hospitalized patients with stable schizophrenia (β = 0.174, 95%CI:0.265 ~ 1.720, p = 0.008). Particularly strong correlations were observed with processing speed T-scores (β = -0.200, 95%CI: -33.446 ~ -7.230, p = 0.03) and executive function T-scores (β = -0.171, 95%CI: -17.277 ~ -2.082, p = 0.013). Binary logistic regression analysis further confirmed that CysC may be a risk factor for exacerbation of cognitive impairment in stable schizophrenia (OR = 12.741, 95%CI: 1.424 ~ 114.005, p = 0.023). The combined serum CysC, β2-MG, and UA test for cognitive function in stable schizophrenia inpatients had an AUC area of 0.71, with a sensitivity and specificity of 79.5% and 60.5%, respectively, and a predictive value superior to that of an independent diagnosis. In hospitalized patients with stable schizophrenia, serum CysC levels are positively correlated with the severity of cognitive impairment, particularly showing significant associations with information processing speed and executive function. CysC may be a risk factor for exacerbating cognitive impairment in these patients. The combined diagnostic value of serum CysC, β2-MG, and UA demonstrated moderate accuracy in identifying stable schizophrenia cognitive impairment. These data support the potential of CysC as a biomarker of cognitive function in stable schizophrenia.
- 15 May 2025
- Published by Springer Nature in BMC Psychiatry
- Vol. 25 (1) , 494
Open AccessRelationship between renal function and cognitive impairment in patients with stable schizophrenia: a multicenter cross-sectional study
Clinically stable inpatients with schizophrenia have generalized impairment of cognitive function along with abnormalities in renal function, but the link between cognitive function and renal function has been underexplored. This study enrolled 216 hospitalized patients with clinically stable schizophrenia. Demographic and renal function parameters were collected from electronic medical records. Cognitive function was assessed using the Chinese Brief Cognitive Test (C-BCT). To analyze the correlations between renal function and processing speed, attention, working memory, and executive function in patients hospitalized with clinically stable schizophrenia. Covariate-adjusted linear and multivariate logistic regression models were constructed to determine the relationship between renal function and cognitive function. ROC analysis was used to further investigate the prediction of renal function indices in assessing stable schizophrenia inpatients. Significant variations in serum Cystatin C (CysC), β2-microglobulin (β2-MG), and uric acid (UA) levels were observed among hospitalized patients with clinically stable schizophrenia across different cognitive impairment severities. Correlation analysis revealed a significant association between serum CysC levels and C-BCT scores in hospitalized patients with stable schizophrenia (β = 0.174, 95%CI:0.265 ~ 1.720, p = 0.008). Particularly strong correlations were observed with processing speed T-scores (β = -0.200, 95%CI: -33.446 ~ -7.230, p = 0.03) and executive function T-scores (β = -0.171, 95%CI: -17.277 ~ -2.082, p = 0.013). Binary logistic regression analysis further confirmed that CysC may be a risk factor for exacerbation of cognitive impairment in stable schizophrenia (OR = 12.741, 95%CI: 1.424 ~ 114.005, p = 0.023). The combined serum CysC, β2-MG, and UA test for cognitive function in stable schizophrenia inpatients had an AUC area of 0.71, with a sensitivity and specificity of 79.5% and 60.5%, respectively, and a predictive value superior to that of an independent diagnosis. In hospitalized patients with stable schizophrenia, serum CysC levels are positively correlated with the severity of cognitive impairment, particularly showing significant associations with information processing speed and executive function. CysC may be a risk factor for exacerbating cognitive impairment in these patients. The combined diagnostic value of serum CysC, β2-MG, and UA demonstrated moderate accuracy in identifying stable schizophrenia cognitive impairment. These data support the potential of CysC as a biomarker of cognitive function in stable schizophrenia.
- Open Access
- 21 April 2025
- Published by Springer Nature in Research Square
Relationship between renal function and cognitive impairment in patients with stable schizophrenia: A multicenter cross-sectional study
Objective Clinically stable inpatients with schizophrenia have generalized impairment of cognition function along with abnormalities in renal function, but the link between cognitive function and renal function has been underexplored. Methods This study enrolled 216 hospitalized patients with clinically stable schizophrenia. Demographic and renal function parameters were collected from electronic medical records. Cognitive function was assessed using the Chinese Brief Cognitive Test (C-BCT). To analyze the correlations between renal function and processing speed, attention, working memory, and executive function in patients hospitalized with clinically stable schizophrenia. Covariate-adjusted linear and multivariate logistic regression models were constructed to determine the relationship between renal function and cognitive function. ROC analysis was used to further investigate the prediction of renal function indices in assessing stable schizophrenia inpatients. Results Significant variations in serum Cystatin C (CysC), β2-microglobulin (β2-MG), and uric acid (UA) levels were observed among hospitalized patients with clinically stable schizophrenia across different cognitive impairment severities. Correlation analysis revealed a significant association between serum CysC levels and C-BCT scores in hospitalized patients with stable schizophrenia(β = 0.174,95%CI:0.265 ~ 1.720,p = 0.008). Particularly strong correlations were observed with processing speed T-scores(β=-0.200,95%CI:-33.446~-7.230,p = 0.03) and executive function T-scores(β=-0.171,95%CI:-17.277~-2.082, p = 0.013). Binary logistic regression analysis further confirmed that CysC may be a risk factor for exacerbation of cognitive impairment in stable schizophrenia(OR = 12.741, 95%CI:1.424 ~ 114.005, p = 0.023). The combined serum CysC, β2-MG, and UA test for cognitive function in stable schizophrenia inpatients had an AUC area of 0.71, with a sensitivity and specificity of 79.5% and 60.5%, respectively, and a predictive value superior to that of an independent diagnosis. Conclusion In hospitalized patients with stable schizophrenia, serum CysC levels are positively correlated with the severity of cognitive impairment, particularly showing significant associations with information processing speed and executive function. CysC may be a risk factor for exacerbating cognitive impairment in these patients. The combined diagnostic value of serum CysC, β2-MG, and UA demonstrated moderate accuracy in identifying stable schizophrenia cognitive impairment. These data support the potential of CysC as a biomarker of cognitive function in stable schizophrenia.
- 21 April 2025
- Published by Springer Nature in Research Square
Open AccessRelationship between renal function and cognitive impairment in patients with stable schizophrenia: A multicenter cross-sectional study
Objective Clinically stable inpatients with schizophrenia have generalized impairment of cognition function along with abnormalities in renal function, but the link between cognitive function and renal function has been underexplored. Methods This study enrolled 216 hospitalized patients with clinically stable schizophrenia. Demographic and renal function parameters were collected from electronic medical records. Cognitive function was assessed using the Chinese Brief Cognitive Test (C-BCT). To analyze the correlations between renal function and processing speed, attention, working memory, and executive function in patients hospitalized with clinically stable schizophrenia. Covariate-adjusted linear and multivariate logistic regression models were constructed to determine the relationship between renal function and cognitive function. ROC analysis was used to further investigate the prediction of renal function indices in assessing stable schizophrenia inpatients. Results Significant variations in serum Cystatin C (CysC), β2-microglobulin (β2-MG), and uric acid (UA) levels were observed among hospitalized patients with clinically stable schizophrenia across different cognitive impairment severities. Correlation analysis revealed a significant association between serum CysC levels and C-BCT scores in hospitalized patients with stable schizophrenia(β = 0.174,95%CI:0.265 ~ 1.720,p = 0.008). Particularly strong correlations were observed with processing speed T-scores(β=-0.200,95%CI:-33.446~-7.230,p = 0.03) and executive function T-scores(β=-0.171,95%CI:-17.277~-2.082, p = 0.013). Binary logistic regression analysis further confirmed that CysC may be a risk factor for exacerbation of cognitive impairment in stable schizophrenia(OR = 12.741, 95%CI:1.424 ~ 114.005, p = 0.023). The combined serum CysC, β2-MG, and UA test for cognitive function in stable schizophrenia inpatients had an AUC area of 0.71, with a sensitivity and specificity of 79.5% and 60.5%, respectively, and a predictive value superior to that of an independent diagnosis. Conclusion In hospitalized patients with stable schizophrenia, serum CysC levels are positively correlated with the severity of cognitive impairment, particularly showing significant associations with information processing speed and executive function. CysC may be a risk factor for exacerbating cognitive impairment in these patients. The combined diagnostic value of serum CysC, β2-MG, and UA demonstrated moderate accuracy in identifying stable schizophrenia cognitive impairment. These data support the potential of CysC as a biomarker of cognitive function in stable schizophrenia.
- Open Access
- 15 April 2025
- Published by Wiley in Advanced Science
- Vol. 12 (21) , e2414550
CXCL13 Damages Blood Spinal Cord Barrier by Promoting RNF6/Sqstm1‐Ubiquitination Induced Autophagy in Experimental Allergic Encephalomyelitis
The damage of blood spinal cord barrier (BSCB) is contributing to the disruption of immune microenvironment within central nervous system during the progression of multiple sclerosis (MS) and experimental allergic encephalomyelitis (EAE). Nevertheless, the underlying mechanisms responsible for barrier impairment remain inadequately understood. Here, by analyzing the protein profiles in peripheral blood serum, chemokine (C‐X‐C motif) ligand 13 (CXCL13) was identified to be increased with the progression of MS and EAE. The absence of CXCL13 resulted in alleviation of EAE symptoms, as evidenced by a reduced clinical score, decreased barrier damage, as well as diminished demyelination and inflammatory response in the spinal cord. In the BSCB model, CXCL13 was found to impair barrier structure and function in a dose‐ and time‐dependent manner, which was associated with exacerbated autophagy in endothelial cells, while the application of autophagy inhibitors partially mitigated this damage. Mechanistically, CXCL13 enhanced the expression of RNF6, an E3 ubiquitin‐protein ligase, facilitating the conjugation to Sqstm1 for the ubiquitination at the K314 residue. These findings suggest that CXCL13 significantly contributes to the impairment of the BSCB by promoting RNF6/Sqstm1‐ubiquitination‐induced autophagy during the progression of EAE, thereby offering a promising diagnostic and therapeutic target for MS.
- 15 April 2025
- Published by Wiley in Advanced Science
- Vol. 12 (21) , e2414550
Open AccessCXCL13 Damages Blood Spinal Cord Barrier by Promoting RNF6/Sqstm1‐Ubiquitination Induced Autophagy in Experimental Allergic Encephalomyelitis
The damage of blood spinal cord barrier (BSCB) is contributing to the disruption of immune microenvironment within central nervous system during the progression of multiple sclerosis (MS) and experimental allergic encephalomyelitis (EAE). Nevertheless, the underlying mechanisms responsible for barrier impairment remain inadequately understood. Here, by analyzing the protein profiles in peripheral blood serum, chemokine (C‐X‐C motif) ligand 13 (CXCL13) was identified to be increased with the progression of MS and EAE. The absence of CXCL13 resulted in alleviation of EAE symptoms, as evidenced by a reduced clinical score, decreased barrier damage, as well as diminished demyelination and inflammatory response in the spinal cord. In the BSCB model, CXCL13 was found to impair barrier structure and function in a dose‐ and time‐dependent manner, which was associated with exacerbated autophagy in endothelial cells, while the application of autophagy inhibitors partially mitigated this damage. Mechanistically, CXCL13 enhanced the expression of RNF6, an E3 ubiquitin‐protein ligase, facilitating the conjugation to Sqstm1 for the ubiquitination at the K314 residue. These findings suggest that CXCL13 significantly contributes to the impairment of the BSCB by promoting RNF6/Sqstm1‐ubiquitination‐induced autophagy during the progression of EAE, thereby offering a promising diagnostic and therapeutic target for MS.
- 4 April 2025
- Published by Elsevier in Neurochemistry International
- Vol. 186, 105975
Suppression of KDM5C mitigates the symptoms of Alzheimer's disease by up-regulating BDNF expression
- 4 April 2025
- Published by Elsevier in Neurochemistry International
- Vol. 186, 105975
Suppression of KDM5C mitigates the symptoms of Alzheimer's disease by up-regulating BDNF expression
- 24 December 2024
- Published by Wiley in Biochemistry and Molecular Biology Education
- Vol. 53 (2) , 171-180
Integration of online and offline teaching mode in biochemistry and molecular biology courses
To enhance the effectiveness of integrating online and offline teaching, 1545 clinical and preventive medicine students from 2019 to 2021 were randomly allocated to two groups, A and B. The curriculum was divided into two segments. Initially, two groups were established for the first segment, covering an introduction to Biomolecular and Material Metabolism. The group A adopted a teaching strategy incorporating “massive open online course + a Social Media platform (WeChat) + Project/Problem‐Based Learning + Flipped classroom”, integrating online and offline methods. The group B followed conventional teaching practices. In the second course segment, which included molecular biology and clinical biochemistry, the two groups had their instructional format switched. Comparative analysis of student satisfaction, learning attitudes, and academic performance between the groups was conducted. The satisfaction survey indicated that the group which adopted the online and offline mode outperformed the conventional teaching group in satisfaction rate, satisfaction scores, excellence rate, and total scores. While both groups exhibited an improvement in learning attitudes, the teaching reform group showed a significantly higher level of enhancement. Furthermore, the reform group achieved superior overall average scores, basic average scores, comprehensive average scores, and an increased rate of excellence compared to the conventional group. The results demonstrate that adopting a blended teaching model significantly improved instructional quality and positively influenced students' engagement and attitudes in biochemistry and molecular biology studies.
- 24 December 2024
- Published by Wiley in Biochemistry and Molecular Biology Education
- Vol. 53 (2) , 171-180
Integration of online and offline teaching mode in biochemistry and molecular biology courses
To enhance the effectiveness of integrating online and offline teaching, 1545 clinical and preventive medicine students from 2019 to 2021 were randomly allocated to two groups, A and B. The curriculum was divided into two segments. Initially, two groups were established for the first segment, covering an introduction to Biomolecular and Material Metabolism. The group A adopted a teaching strategy incorporating “massive open online course + a Social Media platform (WeChat) + Project/Problem‐Based Learning + Flipped classroom”, integrating online and offline methods. The group B followed conventional teaching practices. In the second course segment, which included molecular biology and clinical biochemistry, the two groups had their instructional format switched. Comparative analysis of student satisfaction, learning attitudes, and academic performance between the groups was conducted. The satisfaction survey indicated that the group which adopted the online and offline mode outperformed the conventional teaching group in satisfaction rate, satisfaction scores, excellence rate, and total scores. While both groups exhibited an improvement in learning attitudes, the teaching reform group showed a significantly higher level of enhancement. Furthermore, the reform group achieved superior overall average scores, basic average scores, comprehensive average scores, and an increased rate of excellence compared to the conventional group. The results demonstrate that adopting a blended teaching model significantly improved instructional quality and positively influenced students' engagement and attitudes in biochemistry and molecular biology studies.
- 15 September 2024
- Published by Wiley in Biotechnology and Bioengineering
- Vol. 121 (12) , 3822-3833
The modulation of lung cancer cell motility by Calponin 3 is achieved through its ability to sense and respond to changes in substrate stiffness
The influence of extracellular matrix (ECM) stiffness on cell behavior is a well‐established phenomenon. Tumor development is associated with the stiffening of the ECM. However, the understanding of the role of biomechanical behavior and mechanotransduction pathways in the oncogenesis of tumor cells remains limited. In this study, we constructed in vitro models using Polydimethylsiloxane substrates to create soft and stiff substrates. We then evaluated the migration of lung cancer cells A549 using video‐microscopy and transwell assays. The mechanical properties were assessed through the utilization of atomic force microscopy, Optical Magnetic Twisting Cytometry, and traction force analysis. Additionally, the expression of Calponin 3 (CNN3) was evaluated using reverse transcription‑quantitative PCR and immunofluorescence techniques. Our observations indicate that the presence of a stiff substrate enhances A549 motility, as evidenced by increased stiffness and traction force in A549 cells on the stiff substrate. Furthermore, we observed a decrease in CNN3 expression in A549 cells on the stiff substrate. Notably, when CNN3 was overexpressed, it effectively inhibited the migration and invasion of A549 cells on the stiff substrate. The results of our study provide novel perspectives on the mechanisms underlying cancer cell migration in response to substrate mechanical properties.
- 15 September 2024
- Published by Wiley in Biotechnology and Bioengineering
- Vol. 121 (12) , 3822-3833
The modulation of lung cancer cell motility by Calponin 3 is achieved through its ability to sense and respond to changes in substrate stiffness
The influence of extracellular matrix (ECM) stiffness on cell behavior is a well‐established phenomenon. Tumor development is associated with the stiffening of the ECM. However, the understanding of the role of biomechanical behavior and mechanotransduction pathways in the oncogenesis of tumor cells remains limited. In this study, we constructed in vitro models using Polydimethylsiloxane substrates to create soft and stiff substrates. We then evaluated the migration of lung cancer cells A549 using video‐microscopy and transwell assays. The mechanical properties were assessed through the utilization of atomic force microscopy, Optical Magnetic Twisting Cytometry, and traction force analysis. Additionally, the expression of Calponin 3 (CNN3) was evaluated using reverse transcription‑quantitative PCR and immunofluorescence techniques. Our observations indicate that the presence of a stiff substrate enhances A549 motility, as evidenced by increased stiffness and traction force in A549 cells on the stiff substrate. Furthermore, we observed a decrease in CNN3 expression in A549 cells on the stiff substrate. Notably, when CNN3 was overexpressed, it effectively inhibited the migration and invasion of A549 cells on the stiff substrate. The results of our study provide novel perspectives on the mechanisms underlying cancer cell migration in response to substrate mechanical properties.
- 3 February 2024
- Published by Wiley in Biochemistry and Molecular Biology Education
- Vol. 52 (3) , 323-331
The implementation of an active inquiry learning centered “7E” teaching mode in the cell biology course enhances the learning effects of postgraduate students
The primary objective of science postgraduate education is to foster students' capacity for creative thinking and problem‐solving, particularly in the context of scientific research quality. In order to achieve this goal, the “7E” teaching mood has been implemented in the cell biology course for postgraduate students to promote student‐centered active inquiry learning instead of breaking away from traditional indoctrination‐based teaching methods. This study demonstrates that the implementation of the “7E” teaching mode, through content programming, process design, and effect evaluation, effectively meets the needs of the majority of students, fosters their interest in learning, enhances their performance in comprehensive questioning, and enhances their innovative abilities in scientific research. Consequently, this research offers a theoretical framework and practical foundation for the development of the “7E” teaching mode in postgraduate courses, aiming to cultivate highly skilled scientific professionals.
- 3 February 2024
- Published by Wiley in Biochemistry and Molecular Biology Education
- Vol. 52 (3) , 323-331
The implementation of an active inquiry learning centered “7E” teaching mode in the cell biology course enhances the learning effects of postgraduate students
The primary objective of science postgraduate education is to foster students' capacity for creative thinking and problem‐solving, particularly in the context of scientific research quality. In order to achieve this goal, the “7E” teaching mood has been implemented in the cell biology course for postgraduate students to promote student‐centered active inquiry learning instead of breaking away from traditional indoctrination‐based teaching methods. This study demonstrates that the implementation of the “7E” teaching mode, through content programming, process design, and effect evaluation, effectively meets the needs of the majority of students, fosters their interest in learning, enhances their performance in comprehensive questioning, and enhances their innovative abilities in scientific research. Consequently, this research offers a theoretical framework and practical foundation for the development of the “7E” teaching mode in postgraduate courses, aiming to cultivate highly skilled scientific professionals.